Collegium Pharmaceutical (COLL) Cost of Revenue (2016 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Cost of Revenue of $20.8 million for Q1 2026, down 74.14% year-over-year from $80.4 million in Q1 2025, and down 3.69% quarter-over-quarter from $21.6 million in Q4 2025.
Collegium Pharmaceutical (COLL) Cost of Revenue (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's Cost of Revenue history runs 11 years deep, the most recent figure standing at $20.8 million for Q1 2026.
- In Q1 2026, Cost of Revenue fell 74.14% year-over-year to $20.8 million; the TTM figure through Mar 2026 stood at $146.7 million (down 23.21% YoY), while the FY2025 annual figure was $3.1 million, down 96.56% from the prior year.
- Cost of Revenue for Q1 2026 stood at $20.8 million, down from $21.6 million in the prior quarter.
- The five-year high for Cost of Revenue was $80.4 million in Q1 2025, with the low at $20.0 million in Q2 2024.
- The 5-year median for Cost of Revenue is $29.9 million (2023), against an average of $41.1 million.
- The sharpest annual moves came in 2022 and 2026: Cost of Revenue soared 347.48% in 2022, then plunged 74.14% in 2026.
- Collegium Pharmaceutical's Cost of Revenue stood at $37.6 million in 2022, then tumbled by 45.14% to $20.6 million in 2023, then surged by 36.84% to $28.2 million in 2024, then retreated by 23.38% to $21.6 million in 2025, then slipped by 3.69% to $20.8 million in 2026.
- Business Quant data shows COLL's Cost of Revenue at $20.8 million in Q1 2026, $21.6 million in Q4 2025, and $24.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Collegium Pharmaceutical | 897.05 Mn | 747.74 Mn | 110.29 Mn | 89.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89.59 Mn |
| Jun 30, 2026 | 89.59 Mn |
| Mar 31, 2026 | 20.80 Mn |
| Mar 31, 2026 | 20.80 Mn |
| Dec 31, 2025 | 21.60 Mn |
| Dec 31, 2025 | 21.60 Mn |
| Sep 30, 2025 | 24.72 Mn |
| Sep 30, 2025 | 24.72 Mn |
| Jun 30, 2025 | 79.62 Mn |
| Jun 30, 2025 | 79.62 Mn |
| Mar 31, 2025 | 80.43 Mn |
| Mar 31, 2025 | 80.43 Mn |
| Dec 31, 2024 | 28.19 Mn |
| Dec 31, 2024 | 28.19 Mn |
| Sep 30, 2024 | 62.51 Mn |
| Sep 30, 2024 | 62.51 Mn |
| Jun 30, 2024 | 19.96 Mn |
| Jun 30, 2024 | 19.96 Mn |
| Mar 31, 2024 | 53.47 Mn |
| Mar 31, 2024 | 53.47 Mn |